Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · Infectious Diseases

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 50%High 2 · 50%

Microfilaraemia (mf) prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic

The intervention showed no clear difference in microfilaraemia (mf) prevalence (high certainty).

1 finding from 1 review

Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis 2019 · Cochrane Headline outcomes only
RR 0.95 [0.85, 1.07]
12 studies · 5027 participants
High

Microfilaraemia (mf) prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic

The intervention showed no clear difference in microfilaraemia (mf) prevalence (moderate certainty).

1 finding from 1 review

Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis 2019 · Cochrane Headline outcomes only
RR 0.9 [0.75, 1.09]
7 studies · 1102 participants
Moderate

Microfilaraemia (mf) prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic

The intervention showed no clear difference in microfilaraemia (mf) prevalence (moderate certainty).

1 finding from 1 review

Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis 2019 · Cochrane Headline outcomes only
RR 0.84 [0.54, 1.31]
4 studies · 2519 participants
Moderate

Microfilaraemia (mf) prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic

The intervention showed no clear difference in microfilaraemia (mf) prevalence (high certainty).

1 finding from 1 review

Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis 2019 · Cochrane Headline outcomes only
RR 0.98 [0.81, 1.19]
4 studies · 1406 participants
High